Are night sweats a side effect of Wellbutrin (bupropion) and how should they be managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Night Sweats and Bupropion (Wellbutrin)

Night sweats are not a commonly reported side effect of bupropion (Wellbutrin), and the medication is actually associated with significantly lower rates of sweating compared to SSRIs and SNRIs.

Evidence from FDA Drug Labeling

The official FDA prescribing information for Wellbutrin lists sweating as an adverse reaction that occurred in 6% of patients taking 300 mg/day and 5% taking 400 mg/day of sustained-release bupropion, compared to 2% in placebo groups 1. However, this sweating was reported as a general side effect during the day, not specifically as night sweats 1.

In the seasonal affective disorder trials using Wellbutrin XL, sweating was not listed among the adverse reactions occurring at ≥2% incidence 1. This suggests that sweating with bupropion is relatively uncommon compared to other antidepressants.

Comparative Evidence: Bupropion vs. Other Antidepressants

Bupropion causes significantly less sweating than serotonergic antidepressants (SSRIs and SNRIs). The American College of Physicians guideline notes that while sweating is a common adverse event with second-generation antidepressants overall, bupropion has a more favorable side effect profile in this regard 2.

Research confirms that excessive sweating (hyperhidrosis) is primarily associated with SSRIs, SNRIs (particularly venlafaxine), and tricyclic antidepressants—not bupropion 3, 4. In fact, bupropion's mechanism of action (dopamine and norepinephrine reuptake inhibition without significant serotonergic effects) makes it less likely to cause sweating compared to serotonergic agents 5.

Clinical Evaluation Algorithm

If a patient on bupropion reports night sweats, follow this systematic approach:

1. Rule out other medications first

  • Check for concurrent SSRIs, SNRIs, or other serotonergic agents that are the more likely culprits 3, 4
  • Review all medications for known sweating side effects 4

2. Assess for medical causes unrelated to bupropion

  • Menopause/hormonal changes (prevalence of night sweats ranges from 10% in older primary care patients to 60% in certain populations) 6
  • Infections (tuberculosis, endocarditis, HIV) 6
  • Malignancies (lymphoma, leukemia) 6
  • Autoimmune diseases 6
  • Hyperthyroidism, diabetes, hypoglycemia 6

3. Evaluate temporal relationship

  • Determine if night sweats began after starting bupropion or increasing the dose 1
  • Note that if sweating started before bupropion or has been stable despite bupropion use, the medication is unlikely to be the cause 6

4. Consider dose-related effects

  • The FDA data shows sweating rates of 6% at 300 mg/day and 5% at 400 mg/day 1
  • If sweating is truly bupropion-related, consider dose reduction 3

Management Recommendations

If bupropion is determined to be the cause:

First-line approach:

  • Dose reduction to the lowest effective dose (e.g., from 300 mg to 150 mg daily) 3
  • Monitor for 2–4 weeks to assess if sweating improves while maintaining antidepressant efficacy 3

Second-line approach:

  • Switch to another antidepressant if dose reduction is ineffective or causes loss of therapeutic benefit 3
  • Bupropion already has one of the lowest sweating profiles, so switching may not be necessary unless other factors are present 2, 5

Third-line approach (if bupropion must be continued):

  • Add an anticholinergic agent such as benztropine or oxybutynin 5 mg/day to control sweating symptoms 3, 7
  • Oxybutynin has been shown in a double-blind study to successfully reduce excessive sweating in patients on sertraline, and the same principle may apply to bupropion if sweating occurs 7
  • Monitor for anticholinergic side effects (dry mouth, constipation, urinary retention) 7

If bupropion is NOT the cause:

Most likely scenario: Night sweats are due to another medication (especially if the patient is on an SSRI or SNRI) or an underlying medical condition 3, 4, 6. Address the actual cause rather than discontinuing bupropion unnecessarily.

Key Clinical Pitfalls to Avoid

  • Do not automatically attribute night sweats to bupropion without considering more common causes, as bupropion has one of the lowest sweating rates among antidepressants 2, 5
  • Do not overlook concurrent SSRIs or SNRIs, which are far more likely to cause sweating and night sweats 3, 4
  • Do not discontinue bupropion prematurely without ruling out other etiologies, as the medication is unlikely to be the culprit 6, 5
  • Do not miss serious underlying conditions such as infections, malignancies, or autoimmune diseases that commonly present with night sweats 6

Bottom Line

Bupropion is one of the least likely antidepressants to cause sweating or night sweats. If a patient on bupropion reports night sweats, systematically evaluate for other medications (especially SSRIs/SNRIs), medical conditions, and hormonal changes before attributing the symptom to bupropion 2, 3, 4, 6, 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Antidepressant-induced sweating.

The Annals of pharmacotherapy, 2005

Research

Bupropion: pharmacology and therapeutic applications.

Expert review of neurotherapeutics, 2006

Research

Night sweats: a systematic review of the literature.

Journal of the American Board of Family Medicine : JABFM, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.